Welcome to our dedicated page for Life360 SEC filings (Ticker: LIF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Life360, Inc. (LIF) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures as a Nasdaq-listed issuer. Life360 is a family connection and safety company that reports its financial and operational performance through filings with the U.S. Securities and Exchange Commission, including current reports on Form 8-K and other periodic reports.
In its SEC filings, Life360 presents details on subscription revenue, hardware revenue, and other revenue, which includes data and partnership revenue such as advertising. The company also discloses key performance indicators for its core mobile application, including Monthly Active Users (MAUs), Paying Circles, and Average Revenue Per Paying Circle. These metrics help investors understand the scale and engagement of Life360’s user base and the contribution of its core app to overall results.
Filings may also discuss gross margin, operating expenses, and Adjusted EBITDA, along with narrative explanations of changes in research and development, sales and marketing, and general and administrative costs. Life360 uses non-GAAP measures such as Adjusted EBITDA and core subscription revenue to supplement its GAAP results, and reconciliations are typically included in its financial disclosures.
Corporate actions and material events are reported through Forms such as Form 8-K. For example, an 8-K filed in November 2025 describes Life360’s announcement of financial results and its entry into an Agreement and Plan of Reorganization to acquire Nativo, Inc., an advertising technology company, in a transaction valued at approximately $120 million in cash and stock, subject to customary closing conditions. Such filings outline the structure of significant transactions, key terms, and the expected impact on the company.
On this page, Stock Titan surfaces Life360’s SEC filings as they are made available on EDGAR and enhances them with AI-powered summaries. These summaries are intended to highlight the main points of lengthy documents, such as earnings releases, transaction announcements, and presentations furnished as exhibits, so readers can quickly grasp the context before reviewing the full text. Users can review current reports like Form 8-K for material events, and refer to Life360’s broader set of filings for a more complete view of its financial condition, risk factors, and governance practices.
For investors tracking LIF, the filings page is a central resource to monitor how Life360 describes its business performance, revenue mix, user metrics, and strategic transactions in its own words, directly from its official submissions to the SEC.
Life360 insider sale under pre-set plan Lauren Antonoff, who serves as Chief Executive Officer and a director of Life360, Inc. (LIF), reported the sale of 4,546 shares of the company's common stock on 09/24/2025 at a price of $101.52 per share. The filing states the sale was executed under a Rule 10b5-1 trading plan adopted on November 27, 2024, which the reporting person says was established when they were not aware of any material nonpublic information.
The Form 4 shows the reporting person beneficially owns 333,919 shares following the transaction, which includes 222,277 restricted stock units that convert to common shares upon vesting. The form is signed by an attorney-in-fact and provides the required disclosure of relationship and transaction details.
Life360, Inc. Form 144: An officer or other person plans to sell 4,546 shares of Life360 common stock on 09/24/2025, with an aggregate market value reported as $461,509.92 and the sale venue listed as NASDAQ. The shares were acquired on 06/20/2024 through restricted stock vesting and were received as compensation. The filer also reported four prior sales over the past three months totaling 36,502 shares with reported gross proceeds of $2,482,157.96 across dates from 06/24/2025 to 09/05/2025. The filer certifies no undisclosed material adverse information in connection with this notice.
Charles J. Prober, a director of Life360, Inc. (LIF), reported transactions on 09/15/2025 conducted under a Rule 10b5-1 trading plan. The Form 4 shows an acquisition of 7,930 shares via exercise of stock options at an $11.18 exercise price and a contemporaneous sale of 7,930 shares at $100.24 per share. After the transactions the reporting person’s direct beneficial ownership is reported as 105,456 shares in one line and 111,020 options-related shares in the derivative table; the filing also notes total holdings include 2,036 restricted stock units that convert to common stock upon vesting. The Form 4 states the 10b5-1 plan was adopted on March 14, 2025, and the option vesting schedule is described in the filing.
Life360, Inc. submitted a Rule 144 notice proposing the sale of 7,930 common shares through Fidelity Brokerage Services on 09/15/2025 with an aggregate market value of $794,903.20. The filing reports 77,548,651 shares outstanding. The securities were acquired on 09/15/2025 as options originally granted on 04/12/2022 and the stated payment method is cash. The form also discloses two prior sales by Charles Prober within the past three months: 7,930 shares sold on 07/14/2025 for $510,771.30 and 7,930 shares sold on 08/13/2025 for $667,150.90. The filer attests there is no undisclosed material adverse information.
Chris Hulls, a director of Life360, Inc. (LIF), reports a non‑market transaction on 09/04/2025 in which 7,152 shares of common stock were withheld by the issuer at a per‑share price of $86.65 to satisfy income tax withholding related to the vesting and net settlement of previously reported restricted stock units. After this withholding, the Reporting Person beneficially owns 476,678 shares (this total includes common stock and shares underlying CDIs converted on a 1:3 common stock to CDI ratio). The filing notes 137,853 restricted stock units previously granted and identifies holdings reported indirectly: 195,312 shares held by each of three named irrevocable trusts and 1,846 shares representing the Reporting Person’s proportionate interest in ICCA Labs, LLC. The Form 4 was signed by an attorney‑in‑fact on 09/08/2025.
Life360, Inc. (LIF) insider transaction summary: Chief Executive Officer and Director Lauren Antonoff sold 17,764 shares of Life360 common stock on 09/05/2025 at an average reported price of $90.903 per share. The Form 4 states the sale was a "sell-to-cover" to satisfy tax withholding obligations tied to the vesting and settlement of previously granted restricted stock units (RSUs). After the transaction Antonoff beneficially owned 338,465 shares, which the filing notes includes 222,277 unvested RSUs that convert to one share each upon vesting. The Form 4 was signed by an attorney-in-fact on 09/08/2025.
Life360, Inc. insider transaction by CFO John Burke: On 09/04/2025 the reporting person, John Burke (Chief Financial Officer), had 9,976 shares withheld at a price of $86.65 to satisfy income tax withholding in connection with the vesting and net settlement of previously granted restricted stock units. After this withholding, the filing shows Mr. Burke beneficially owns 101,255 shares directly and 63,030 shares indirectly (held by the Russell John Burke Revocable Trust). The form notes there are 91,732 restricted stock units previously granted that represent contingent rights to receive common stock upon vesting.
Form 144 filed for Life360, Inc. (LIF) reporting a proposed sale of 17,764 common shares through Fidelity Brokerage Services with an aggregate market value of $1,614,806.22, and an approximate sale date of 09/05/2025 on NASDAQ. The filing states these shares were acquired by restricted stock vesting from the issuer and that payment is compensation. The filing also discloses four prior dispositions by the same seller in the past three months totaling 32,446 shares for gross proceeds of $2,252,183.02. The notice includes the seller's representation that they are not aware of any undisclosed material adverse information.
Life360 director John Philip Coghlan reported sales of common stock under a Rule 10b5-1 plan on 09/02/2025. The Form 4 shows two reported sale groupings: 508 shares sold at a weighted average price of $87.03 (individual trades ranged $86.50–$87.49) and 2,617 shares sold at a weighted average price of $88.33 (individual trades ranged $87.74–$88.71).
After these transactions the reporting person beneficially owned 11,992 shares held by the John Coghlan Living Trust and 9,375 shares held by the same trust, plus 67,604 shares held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust. The filings note 3,344 restricted stock units that convert to shares upon vesting. The sales were effected pursuant to a 10b5-1 plan adopted December 6, 2024.
Life360, Inc. reporting person Lauren Antonoff, who serves as Chief Executive Officer and a director, received a grant of 52,997 restricted stock units (RSUs) on 09/01/2025. Each RSU converts to one share upon settlement and the grant vests monthly at a rate of 1/48th beginning September 1, 2025, subject to continued service. Following the grant, the filing reports 356,229 shares/RSU-equivalents beneficially owned, which includes 258,971 previously granted RSUs. The acquisition was recorded at a $0 price (typical for RSU grants). The Form 4 was signed by an attorney-in-fact on 09/03/2025.
FAQ
What is the current stock price of Life360 (LIF)?
What is the market cap of Life360 (LIF)?
